Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNOW: Eplerenone vs Spironolactone in Heart Failure Patients with Glucose Intolerance or Type 2 Diabetes
NCT01586442Phase 3Completed
- Sponsor
- Montréal Heart Institute
- Start
- Mar 2012
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of eplerenone in heart failure (HF), sponsored by Montréal Heart Institute. Started Mar 2012; status: completed.
02
Drugs
eplerenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01586442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01586442.